VMD Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
78.1M
+3.6%
75.4M
-1.0%
76.2M
+5.9%
71.9M
+14.0%
63.1M
Cost of Revenue
33.0M
+1.4%
32.6M
+1.6%
32.1M
+4.9%
30.6M
+16.1%
26.3M
Gross Profit
45.0M
+5.2%
42.8M
-2.9%
44.1M
+6.7%
41.3M
+12.6%
36.7M
Operating Expenses
40.1M
+4.8%
38.2M
+7.6%
35.5M
+0.7%
35.3M
+9.0%
32.3M
R&D
504.0K
-13.0%
579.0K
-3.2%
598.0K
-22.8%
775.0K
-8.5%
847.0K
SG&A
39.2M
+5.2%
37.2M
+7.9%
34.5M
+1.2%
34.1M
+9.5%
31.1M
Operating Income
5.0M
+8.1%
4.6M
-46.3%
8.6M
+41.6%
6.1M
+38.5%
4.4M
EBITDA
12.5M
+2.2%
12.2M
-24.3%
16.2M
+18.8%
13.6M
+20.7%
11.3M
Net Income
2.9M
+6.9%
2.7M
-53.4%
5.8M
+61.6%
3.6M
+10.8%
3.3M
EPS (Basic)
$0.07
+0.0%
$0.07
-53.3%
$0.15
+66.7%
$0.09
+12.5%
$0.08
EPS (Diluted)
$0.07
+16.7%
$0.06
-57.1%
$0.14
+55.6%
$0.09
+12.5%
$0.08
Shares (Diluted)
41.1M
+1.6%
40.5M
+1.0%
40.1M
-1.0%
40.5M
-1.4%
41.1M
Viemed Healthcare, Inc. Common Shares (VMD) โ€” Financials